Epithelial stem cells, wound healing and cancer

Nature Reviews Cancer

Volumn 12, Issue 3, 2012, Pages 170-180

  Arwert, Esther N ^a,b   Hoste, Esther ^a   Watt, Fiona M ^a  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKERATIN 15; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN; WNT PROTEIN;

ANGIOGENESIS; B LYMPHOCYTE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; EPITHELIUM CELL; FIBROBLAST; FIBROSIS; HAIR FOLLICLE; INFLAMMATION; KERATINOCYTE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; PAPILLOMA; PRIORITY JOURNAL; REVIEW; SEBACEOUS GLAND TUMOR; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; STEM CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WOUND HEALING;

ANIMALS; EPITHELIAL CELLS; HUMANS; SKIN NEOPLASMS; STEM CELLS; WOUND HEALING;

EID: 84857570226     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3217     Document Type: Review

References (149)

1. Watt, F. M. & Driskell, R. R. The therapeutic potential of stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 365, 155-163 (2010).
2. Gonda, T. A., Tu, S. & Wang, T. C. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 8, 2005-2013 (2009).
3. Dunham, L. J. Cancer in man at site of prior benign lesion of skin or mucous membrane: a review. Cancer Res. 32, 1359-1374 (1972).
4. Hartnett, L. & Egan, L. J. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 10 Jan 2012 (doi:10.1093/carcin/ bgs006).
5. Pawlotsky, J. M. Pathophysiology of hepatitis C virus infection and related liver disease. Trends Microbiol. 12, 96-102 (2004).
6. Wang, X. W. et al. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181-182, 43-47 (2002).
7. Ruggiero, P. Helicobacter pylori and inflammation. Curr. Pharm. Des. 16, 4225-4236 (2010).
8. Walter, N. D. et al. Wound healing after trauma may predispose to lung cancer metastasis: review of potential mechanisms. Am. J. Respir. Cell Mol. Biol. 44, 591-596 (2011).
9. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659 (1986).
10. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
11. Shaw, T. J. & Martin, P. Wound repair at a glance. J. Cell Sci. 122, 3209-3213 (2009).
12. Schafer, M. & Werner, S. Cancer as an overhealing wound: an old hypothesis revisited. Nature Rev. Mol. Cell Biol. 9, 628-638 (2008).
13. Ortiz-Urda, S. et al. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307, 1773-1776 (2005).
14. South, A. P. & O'Toole, E. A. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma. Dermatol. Clin. 28, 171-178 (2010).
15. Martins-Green, M., Boudreau, N. & Bissell, M. J. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res. 54, 4334-4341 (1994).
16. Dolberg, D. S., Hollingsworth, R., Hertle, M. & Bissell, M. J. Wounding and its role in RSV-mediated tumor formation. Science 230, 676-678 (1985).
17. Pedersen, T. X. et al. Laser capture microdissectionbased in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma. Oncogene 22, 3964-3976 (2003).
18. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
19. Egeblad, M., Nakasone, E. S. & Werb, Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 18, 884-901 (2010).
20. Chang, H. Y. et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, e7 (2004).
21. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
22. Silva-Vargas, V. et al. β-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell 9, 121-131 (2005).
23. Gat, U., Das Gupta, R., Degenstein, L. & Fuchs, E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 95, 605-614 (1998).
24. Nguyen, H. et al. Tcf3 and Tcf4 are essential for longterm homeostasis of skin epithelia. Nature Genet. 41, 1068-1075 (2009).
25. Jensen, K. B. et al. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell 4, 427-439 (2009).
26. Taylor, G., Lehrer, M. S., Jensen, P. J., Sun, T. T. & Lavker, R. M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102, 451-461 (2000).
27. Ito, M. et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nature Med. 11, 1351-1354 (2005).
28. Jaks, V. et al. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nature Genet. 40, 1291-1299 (2008).
29. Nowak, J. A., Polak, L., Pasolli, H. A. & Fuchs, E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 3, 33-43 (2008).
30. Vidal, V. P. et al. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr. Biol. 15, 1340-1351 (2005).
31. Snippert, H. J. et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385-1389 (2010).
32. Nijhof, J. G. et al. The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells. Development 133, 3027-3037 (2006).
33. Brownell, I., Guevara, E., Bai, C. B., Loomis, C. A. & Joyner, A. L. Nerve-derived sonic hedgehog defines a niche for hair follicle stem cells capable of becoming epidermal stem cells. Cell Stem Cell 8, 552-565 (2011). This study demonstrates that SHH-responding perineural bulge cells incorporate into healing skin wounds where they can change their lineage into epidermal stem cells.
34. Levy, V., Lindon, C., Zheng, Y., Harfe, B. D. & Morgan, B. A. Epidermal stem cells arise from the hair follicle after wounding. FASEB J. 21, 1358-1366 (2007).
35. Horsley, V. et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 126, 597-609 (2006).
36. Clayton, E. et al. A single type of progenitor cell maintains normal epidermis. Nature 446, 185-189 (2007).
37. Langton, A. K., Herrick, S. E. & Headon, D. J. An extended epidermal response heals cutaneous wounds in the absence of a hair follicle stem cell contribution. J. Invest. Dermatol. 128, 1311-1318 (2008).
38. Rhee, H., Polak, L. & Fuchs, E. Lhx2 maintains stem cell character in hair follicles. Science 312, 1946-1949 (2006).
39. Mardaryev, A. N. et al. Lhx2 differentially regulates Sox9, Tcf4 and Lgr5 in hair follicle stem cells to promote epidermal regeneration after injury. Development 138, 4843-4852, (2011).
40. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
41. Oro, A. E. & Higgins, K. Hair cycle regulation of Hedgehog signal reception. Dev. Biol. 255, 238-248 (2003).
42. Chiang, C. et al. Essential role for Sonic hedgehog during hair follicle morphogenesis. Dev. Biol. 205, 1-9 (1999).
43. St-Jacques, B. et al. Sonic hedgehog signaling is essential for hair development. Curr. Biol. 8, 1058-1068 (1998).
44. Oro, A. E. et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276, 817-821 (1997).
45. Aszterbaum, M., Beech, J. & Epstein, E. H. Jr. Ultraviolet radiation mutagenesis of hedgehog pathway genes in basal cell carcinomas. J. Investig. Dermatol. Symp. Proc. 4, 41-45 (1999).
46. neo67/+ mice exposed to radiation. Cancer Res. 66, 6606-6614 (2006).
47. Grachtchouk, M. et al. Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations. J. Clin. Invest. 121, 1768-1781 (2011).
48. Grachtchouk, M. et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nature Genet. 24, 216-217 (2000).
49. Kasper, M. et al. Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes. Proc. Natl Acad. Sci. USA 108, 4099-4104 (2011).
50. Youssef, K. K. et al. Identification of the cell lineage at the origin of basal cell carcinoma. Nature Cell Biol. 12, 299-305 (2011).
51. Wong, S. Y. & Reiter, J. F. Wounding mobilizes hair follicle stem cells to form tumors. Proc. Natl Acad. Sci. USA 108, 4093-4098 (2011). References 49 and 51 demonstrate that BCC-like tumours can originate from stem cells that normally reside in the bulge of the hair follicle, and that wounding stimulates stem cell migration and tumour promotion.
52. +/- mice. Cancer Cell 19, 114-124 (2011).
53. Winton, D. J., Blount, M. A. & Ponder, B. A. Polyclonal origin of mouse skin papillomas. Br. J. Cancer 60, 59-63 (1989).
54. Chan, E. F., Gat, U., McNiff, J. M. & Fuchs, E. A common human skin tumour is caused by activating mutations in β-catenin. Nature Genet. 21, 410-413 (1999).
55. Takeda, H. et al. Human sebaceous tumors harbor inactivating mutations in LEF1. Nature Med. 12, 395-397 (2006).
56. Lo Celso, C., Prowse, D. M. & Watt, F. M. Transient activation of β-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 131, 1787-1799 (2004).
57. Niemann, C., Owens, D. M., Schettina, P. & Watt, F. M. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type. Cancer Res. 67, 2916-2921 (2007).
58. Niemann, C., Owens, D. M., Hulsken, J., Birchmeier, W. & Watt, F. M. Expression of ΔNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours. Development 129, 95-109 (2002).
59. Malanchi, I. et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 452, 650-653 (2008).
60. Baker, C. M., Verstuyf, A., Jensen, K. B. & Watt, F. M. Differential sensitivity of epidermal cell subpopulations to β-catenin-induced ectopic hair follicle formation. Dev. Biol. 343, 40-50 (2010).
61. Cheon, S. S. et al. β-catenin regulates wound size and mediates the effect of TGF-β in cutaneous healing. FASEB J. 20, 692-701 (2006).
62. Fathke, C. et al. Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol. 7, 4 (2006).
63. Okuse, T., Chiba, T., Katsuumi, I. & Imai, K. Differential expression and localization of WNTs in an animal model of skin wound healing. Wound Repair Regen. 13, 491-497 (2005).
64. Cheon, S. S. et al. β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc. Natl Acad. Sci. USA 99, 6973-6978 (2002).
65. Ridky, T. W. & Khavari, P. A. Pathways sufficient to induce epidermal carcinogenesis. Cell Cycle 3, 621-624 (2004).
66. Owens, D. M. & Watt, F. M. Contribution of stem cells and differentiated cells to epidermal tumours. Nature Rev. Cancer 3, 444-451 (2003).
67. Lapouge, G. et al. Identifying the cellular origin of squamous skin tumors. Proc. Natl Acad. Sci. USA 108, 7431-7436 (2011).
68. White, A. C. et al. Defining the origins of Ras/p53-mediated squamous cell carcinoma. Proc. Natl Acad. Sci. USA 108, 7425-7430 (2011).
69. Schober, M. & Fuchs, E. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl Acad. Sci. USA 108, 10544-10549 (2011).
70. Sibilia, M. et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211-220 (2000).
71. Bailleul, B. et al. Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62, 697-708 (1990).
72. Greenhalgh, D. A. et al. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog. 7, 99-110 (1993).
73. Brown, K., Strathdee, D., Bryson, S., Lambie, W. & Balmain, A. The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr. Biol. 8, 516-524 (1998).
74. Di Giovanni, J., Bhatt, T. S. & Walker, S. E. C57BL/6 mice are resistant to tumor promotion by full thickness skin wounding. Carcinogenesis 14, 319-321 (1993).
75. Balmain, A. Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108, 145-152 (2002).
76. Popova, N. V., Teti, K. A., Wu, K. Q. & Morris, R. J. Identification of two keratinocyte stem cell regulatory loci implicated in skin carcinogenesis. Carcinogenesis 24, 417-425 (2003).
77. Perez-Losada, J. & Balmain, A. Stem-cell hierarchy in skin cancer. Nature Rev. Cancer 3, 434-443 (2003).
78. Li, F. et al. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci. Signal 3 ra13 (2010).
79. Owens, D. M. & Watt, F. M. Influence of β1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: α3β1, but not α2β1, suppresses malignant conversion. Cancer Res. 61, 5248-5254 (2001).
80. Janes, S. M. & Watt, F. M. New roles for integrins in squamous-cell carcinoma. Nature Rev. Cancer 6, 175-183 (2006).
81. Hobbs, R. M., Silva-Vargas, V., Groves, R. & Watt, F. M. Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J. Invest. Dermatol. 123, 503-515 (2004).
82. Arwert, E. N. et al. Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate. Proc. Natl Acad. Sci. USA 107, 19903-19908 (2010). This study shows that differentiated epidermal cells can initiate tumour formation without reacquiring the ability to divide and that they do so by triggering an inflammatory infiltrate.
83. Huang, Q. et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nature Med. 17, 860-866 (2011).
84. Tang, D., Kang, R., Zeh, H. J. & Lotze, M. T. Highmobility group BOX 1 and cancer. Biochim. Biophys. Acta 1799, 131-140 (2010).
85. Lowell, S., Jones, P., Le Roux, I., Dunne, J. & Watt, F. M. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Curr. Biol. 10, 491-500 (2000).
86. Blanpain, C., Lowry, W. E., Pasolli, H. A. & Fuchs, E. Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev. 20, 3022-3035 (2006).
87. Estrach, S., Ambler, C. A., Lo Celso, C., Hozumi, K. & Watt, F. M. Jagged 1 is a β-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development 133, 4427-4438 (2006).
88. Demehri, S., Turkoz, A. & Kopan, R. Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16, 55-66 (2009). This study shows that loss of Notch1 in epidermal keratinocytes promotes tumorigenesis non-cell autonomously by impairing skin barrier integrity and creating a wound-like environment in the skin.
89. Nicolas, M. et al. Notch1 functions as a tumor suppressor in mouse skin. Nature Genet. 33, 416-421 (2003).
90. Ambler, C. A. & Watt, F. M. Adult epidermal Notch activity induces dermal accumulation of T cells and neural crest derivatives through upregulation of jagged 1. Development 137, 3569-3579 (2010).
91. Demehri, S. et al. Notch-deficient skin induces a lethal systemic B-lymphoproliferative disorder by secreting TSLP, a sentinel for epidermal integrity. PLoS Biol. 6, e123 (2008).
92. Dumortier, A. et al. Atopic dermatitis-like disease and associated lethal myeloproliferative disorder arise from loss of Notch signaling in the murine skin. PLoS ONE 5, e9258 (2010).
93. Scholl, F. A., Dumesic, P. A. & Khavari, P. A. Mek1 alters epidermal growth and differentiation. Cancer Res. 64, 6035-6040 (2004).
94. Vassar, R., Hutton, M. E. & Fuchs, E. Transgenic overexpression of transforming growth factor α bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol. 12, 4643-4653 (1992).
95. Dominey, A. M. et al. Targeted overexpression of transforming growth factor a in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ. 4, 1071-1082 (1993).
96. Schioppa, T. et al. B regulatory cells and the tumorpromoting actions of TNF-α during squamous carcinogenesis. Proc. Natl Acad. Sci. USA 108, 10662-10667 (2011).
97. Andreu, P. et al. FcRγ activation regulates inflammation associated squamous carcinogenesis. Cancer Cell 17, 121-134 (2010).
98. De Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (2005).
99. Szabowski, A. et al. c-Jun. and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103, 745-755 (2000).
100. Arwert, E. N. et al. Upregulation of CD26 expression in epithelial cells and stromal cells during woundinduced skin tumour formation. Oncogene 18 Jul. 2011 (doi:10.1038/onc.2011.298).
101. Wagers, A. J., Sherwood, R. I., Christensen, J. L. & Weissman, I. L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259 (2002).
102. Ishii, G. et al. In vivo characterization of bone marrowderived fibroblasts recruited into fibrotic lesions. Stem Cells 23, 699-706 (2005).
103. Fathke, C. et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 22, 812-822 (2004).
104. Sasaki, M. et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol. 180, 2581-2587 (2008).
105. Brittan, M. et al. Bone marrow cells engraft within the epidermis and proliferate in vivo with no evidence of cell fusion. J. Pathol. 205, 1-13 (2005).
106. Wagner, J. E. et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 363, 629-639 (2010).
107. Tamai, K. et al. PDGFRα}-positive cells in bone marrow are mobilized by high mobility group BOX 1 (HMGB1) to regenerate injured epithelia. Proc. Natl Acad. Sci. USA 108, 6609-6614 (2011). These authors identified a specific subset of bone marrow-derived cells with epidermal differentiation potential that can contribute to skin graft re-epithelialization.
108. auf dem Keller, U. et al. Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing. Mol. Cell. Biol. 26, 3773-3784 (2006).
109. Chida, K. et al. Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res. 63, 2404-2408 (2003).
110. Gonzalez-Suarez, E. et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619-2630 (2001).
111. Guasch, G. et al. Loss of TGFp signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 12, 313-327, (2007).
112. Wakabayashi, Y., Mao, J. H., Brown, K., Girardi, M. & Balmain, A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 445, 761-765 (2007).
113. Schultz, G., Rotatori, D. S. & Clark, W EGF and TGF-α in wound healing and repair. J. Cell. Biochem. 45, 346-352 (1991).
114. Wang, D. et al. Autocrine TGFα expression in the regulation of initiation of human colon carcinoma growth. J. Cell. Physiol. 177, 387-395 (1998).
115. Kim, I., Mogford, J. E., Chao, J. D. & Mustoe, T. A. Wound epithelialization deficits in the transforming growth factor-α knockout mouse. Wound Repair Regen. 9, 386-390 (2001).
116. Ortega, S., Ittmann, M., Tsang, S. H., Ehrlich, M. & Basilico, C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl Acad. Sci. USA 95, 5672-5677 (1998).
117. Yang, F., Strand, D. W. & Rowley, D. R. Fibroblast growth factor-2 mediates transforming growth factor-p action in prostate cancer reactive stroma. Oncogene 27, 450-459 (2008).
118. Nissen, N. N. et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152, 1445-1452 (1998).
119. Hebda, P. A., Klingbeil, C. K., Abraham, J. A. & Fiddes, J. C. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J. Invest. Dermatol. 95, 626-631 (1990).
120. Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. & Sporn, M. B. Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155-7160 (1983).
121. Crowe, M. J., Doetschman, T. & Greenhalgh, D. G. Delayed wound healing in immunodeficient TGF-β 1 knockout mice. J. Invest. Dermatol. 115, 3-11 (2000).
122. Roberts, A. B. et al. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA 83, 4167-4171 (1986).
123. Ikushima, H. & Miyazono, K. TGFβ signalling: a complex web in cancer progression. Nature Rev. Cancer 10, 415-424 (2010).
124. Honjo, Y. et al. TGF-β receptor I conditional knockout mice develop spontaneous squamous cell carcinoma. Cell Cycle 6, 1360-1366 (2007).
125. Giampieri, S. et al. Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility. Nature Cell Biol. 11, 1287-1296 (2009).
126. Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333-345 (2004).
127. Crawford, Y. et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15, 21-34 (2009).
128. Kane, C. J., Hebda, P. A., Mansbridge, J. N. & Hanawalt, P. C. Direct evidence for spatial and temporal regulation of transforming growth factor β 1 expression during cutaneous wound healing. J. Cell. Physiol. 148, 157-173 (1991).
129. Li, H. et al. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics. J. Surg. Res. 145, 41-48 (2008).
130. Bates, D. O. & Jones, R. O. The role of vascular endothelial growth factor in wound healing. Int. J. Low. Extrem. Wounds 2, 107-120 (2003).
131. Eichholz, A., Merchant, S. & Gaya, A. M. Anti-angiogenesis therapies: their potential in cancer management. Onco Targets Ther. 3, 69-82 (2010).
132. Lewis, A. M., Varghese, S., Xu, H. & Alexander, H. R. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4, 48 (2006).
133. Gallucci, R. M. et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 14, 2525-2531 (2000).
134. Schafer, Z. T. & Brugge, J. S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117, 3660-3663 (2007).
135. Mocellin, S. & Nitti, D. TNF and cancer: the two sides of the coin. Front. Biosci. 13, 2774-2783 (2008).
136. Mori, R., Kondo, T., Ohshima, T., Ishida, Y. & Mukaida, N. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16, 963-974 (2002).
137. Hamilton, J. A. Colony-stimulating factors in inflammation and autoimmunity. Nature Rev. Immunol. 8, 533-544 (2008).
138. Wu, L., Yu, Y. L., Galiano, R. D., Roth, S. I. & Mustoe, T. A. Macrophage colony-stimulating factor accelerates wound healing and upregulates TGF-β1 mRNA levels through tissue macrophages. J. Surg. Res. 72, 162-169 (1997).
139. Wyckoff, J. et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029 (2004).
140. -/- mice. Am. J. Pathol. 159, 457-463 (2001).
141. Soria, G. & Ben-Baruch, A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 267, 271-285 (2008).
142. Kogan-Sakin, I. et al. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 30, 698-705 (2009).
143. Wang, D. et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203, 941-951 (2006).
144. Rennekampff, H. O. et al. Role of melanoma growth stimulatory activity (MGSA/gro) on keratinocyte function in wound healing. Arch. Dermatol. Res. 289, 204-212 (1997).
145. Matsuo, Y. et al. CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int. J. Cancer 124, 853-861 (2009).
146. Rennekampff, H. O. et al. Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J. Surg. Res. 93, 41-54 (2000).
147. Pan, J. et al. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol. Cancer 5, 56 (2006).
148. Toksoy, A., Muller, V., Gillitzer, R. & Goebeler, M. Biphasic expression of stromal cell-derived factor-1 during human wound healing. Br. J. Dermatol. 157, 1148-1154 (2007).
149. Yasumoto, K. et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 66, 2181-2187 (2006).